Edition:
India

Invacare Corp (IVC.N)

IVC.N on New York Stock Exchange

17.85USD
23 Feb 2018
Change (% chg)

$-0.12 (-0.67%)
Prev Close
$17.97
Open
$18.15
Day's High
$18.15
Day's Low
$17.55
Volume
48,074
Avg. Vol
80,146
52-wk High
$19.00
52-wk Low
$10.25

Summary

Name Age Since Current Position

Matthew Monaghan

49 2015 Chairman of the Board, President, Chief Executive Officer

Kathleen Leneghan

54 2018 Chief Financial Officer, Senior Vice President

Anthony LaPlaca

58 2009 Senior Vice President, General Counsel, Secretary

Dean Childers

50 2015 Senior Vice President, General Manager - North America

Ralf Ledda

49 2016 Senior Vice President, General Manager - Europe, Middle East and Africa

Martiny Harris

60 2015 Lead Independent Director

Barbara Bodem

49 2017 Director

Susan Alexander

60 2016 Independent Director

Marc Gibeley

52 2015 Independent Director

Michael Merriman

61 2014 Independent Director

Clifford Nastas

54 2015 Independent Director

Baiju Shah

45 2011 Independent Director

Lara Mahoney

Vice President - Investor Relations and Corporate Communications

Biographies

Name Description

Matthew Monaghan

Mr. Matthew E. Monaghan is Chairman of the Board, President, Chief Executive Officer of the Company. Prior to joining Invacare, Mr. Monaghan served as a business unit leader at Zimmer Holdings (now Zimmer Biomet NYSE: ZBH), a major orthopedic implant company, serving first as Vice President and General Manager of the company’s Global Hips business (December 2009 to January 2014) and later as Senior Vice President of Hips and Reconstructive Research (January 2014 until joining Invacare). While at Zimmer, Mr. Monaghan was responsible for the Hip division’s new product development, engineering, marketing, clinical studies, quality, regulatory affairs and results of the shared sales and supply chain functions. Later, those responsibilities also included directing global research for various areas of material, process and product innovation. Prior to joining Zimmer in 2009, Mr. Monaghan spent eight years as an operating executive for two leading private equity firms, Texas Pacific Group (TPG) and Cerberus Capital Management, where he led acquisitions and operational improvements of portfolio companies, which included the carve-out from Baxter Healthcare of a global medical business, making significant improvements at a U.S. personal insurance business and as COO of a consumer durable goods business spun off from Newell-Rubbermaid. For the first 13 years of his career, Mr. Monaghan held various engineering, financial and management positions at General Electric (NYSE:GE). Since November 2016, Mr. Monaghan has served as a director of INC Research (NASDAQ: INCR), a contract research organization serving the needs of pharmaceutical clients.

Kathleen Leneghan

Ms. Kathleen P. Leneghan serves as Chief Financial Officer, Senior Vice President of the Company. Ms. Leneghan has been in the role of interim Chief Financial Officer of the company since November 26, 2017. Prior to her promotion, Ms. Leneghan was vice president and corporate controller since 2003. She has been with Invacare for 27 years, serving in various financial roles in both North America and Europe. Prior to joining Invacare, Ms. Leneghan was an audit manager with Ernst & Young LLP.

Anthony LaPlaca

Mr. Anthony C. LaPlaca is Senior Vice President, General Counsel, Secretary of the Company. He was appointed Senior Vice President, General Counsel and Secretary effective January 2009. Previously, Mr. LaPlaca served as Vice President and General Counsel for six and a half years with Bendix Commercial Vehicle Systems LLC, a member of the Knorr-Bremse group, a supplier of commercial vehicle safety systems. Prior to that, he served as Vice President and General Counsel to Honeywell Transportation & Power Systems and General Counsel to Honeywell Commercial Vehicle Systems LLC.

Dean Childers

Mr. Dean J. Childers is Senior Vice President, General Manager - North America of the Company. Prior to joining the company, Mr. Childers served as Vice President, Business Operations at Integra Lifesciences, Inc., Plainsboro NJ (NASDAQ: IART), a life sciences company focused on regenerative technologies and orthopedics, from September 2014 until May 2015. From 2010-2014, Mr. Childers served as Vice President, Logistics at Zimmer, Inc., Warsaw, Indiana (NYSE:ZMH), an orthopedic device company participating in the joint reconstruction, trauma, sports medicine, surgical equipment, spine and dental markets.

Ralf Ledda

Mr. Ralf Ledda is Senior Vice President, General Manager - Europe, Middle East and Africa of the Company. He has over 20 years of proven leadership experience at Alber GmbH, Invacare's German-based subsidiary that specializes in innovative electromotive technology and power add-on devices used with medical and recreational products. Most recently, he was the managing director of Alber. Mr. Ledda joined Alber in 1995. He assumed responsibility for the company when it transitioned from its founding family ownership to Invacare. During his tenure, he has been responsible for all aspects of the company's operations including overseeing the launch of many innovative devices, including the current Alber Scalamobil stairclimbing systems, multiple power assist devices for manual wheelchairs, and Neodrive technology for e-bicycles. As part of Invacare's ongoing transformation to focus on clinically complex and post-acute care, the company continues to expand the availability of Alber products. Mr. Ledda has a degree in industrial engineering from the University of Munich. Prior to joining Alber, Mr. Ledda worked at Siemens AG.

Martiny Harris

Dr. C. Martin Harris, M.D. is Lead Independent Director of the Company. He also served as Invacare's Interim Chairman of the Board from December 2014 until May 2015. Since December 2016, Dr. Harris has served as the Associate Vice President of the Health Enterprise and Chief Business Officer of the Dell Medical School at The University of Texas, Austin. From 1996 until October 2016, Dr. Harris served as the Chief Information Officer and Chairman of the Information Technology Division of The Cleveland Clinic Foundation in Cleveland, Ohio and a Staff Physician for The Cleveland Clinic Hospital and The Cleveland Clinic Foundation Department of General Internal Medicine. Dr. Harris served from 2000 to 2016 as the Executive Director of e-Cleveland Clinic, a series of e-health clinical programs offered over the internet. Dr. Harris serves as a Director and member of the Audit Committee of HealthStream Inc. (NASDAQ: HSTM), Nashville, Tennessee, which provides internet-based learning and research solutions for the training, information, and education needs of the healthcare industry in the United States. He also serves on the Boards of Directors of Thermo Fisher Scientific Inc. (NYSE: TMO), Waltham, Massachusetts, which provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics and of Colgate Palmolive Company (NYSE: CL), New York, NY., a consumer products producer of household, dental and oral consumer products.

Barbara Bodem

Ms. Barbara W. Bodem is Director of the Company. Ms. Bodem has served as senior vice president of finance for Mallinckrodt plc (NYSE: MNK), a global specialty pharmaceutical company, since October 2015. Prior to that, Ms. Bodem served in a variety of financial roles both in the United States and United Kingdom for Eli Lilly and Company (NYSE: LLY). Her most recent role at Eli Lilly was chief financial officer for the Lilly Oncology business. Ms. Bodem received both her B.S. and M.B.A degrees from Indiana University.

Susan Alexander

Ms. Susan H. Alexander, Esq. is Independent Director of the Company. She serves as the Executive Vice President, Chief Legal, Corporate Services and Secretary of Biogen Inc. (NASDAQ: BIIB), a biopharmaceutical company, since March 2017. Ms. Alexander has served as Executive Vice President, Chief Legal Officer and Corporate Secretary of Biogen from 2011 until March 2017 and as Executive Vice President, General Counsel and Corporate Secretary of Biogen from 2006 to 2011. Prior to joining Biogen, Ms. Alexander served as the Senior Vice President, General Counsel and Corporate Secretary of PAREXEL International Corporation (NASDAQ: PRXL), a biopharmaceutical services company from 2003 to 2006. From 2001 to 2003, Ms. Alexander served as General Counsel of IONA Technologies, a software company. From 1995 to 2001, Ms. Alexander served as Counsel at Cabot Corporation, a specialty chemicals and performance materials company. Prior to that, Ms. Alexander was a partner at the law firms of Hinckley, Allen & Snyder and Fine & Ambrogne.

Marc Gibeley

Mr. Marc M. Gibeley is Independent Director of the Company. He serves as Chief Executive Officer and Director of Scientific Intake Ltd. Co., a medical device and digital healthcare company focused on weight management and the prevention of obesity related chronic diseases, since October 2016. Prior to joining Scientific Intake, Mr. Gibeley served as Head of Diabetes Care North America for Roche Holding AG (SIX: RO), a leading research-focused pharmaceuticals and diagnostics healthcare company from 2011 through 2016. Mr. Gibeley served as the President and Chief Executive Officer of WaveRx, a venture-backed diabetes neuropathy medical device company, from 2008 through 2011. Prior to joining WaveRx, Mr. Gibeley worked for several consumer packaged goods companies, including Procter & Gamble (NYSE: PG), Eastman Kodak (NYSE: KODK) and Kraft Foods (NASDAQ: KHC).

Michael Merriman

Mr. Michael J. Merriman, Jr. is no longer a Independent Director of the Company effective May 2018 (Annual Shareholder Meeting in May). He has been an Operating Advisor of Resilience Capital Partners LLC, a private equity firm focused on principal investing in lower middle market underperforming and turnaround situations, since June 2008. Mr. Merriman served as President and Chief Executive Officer of The Lamson & Sessions Co. (formerly, NYSE: LMS), Cleveland, Ohio, a manufacturer of thermoplastic conduit, fittings and electrical switch and outlet boxes from November 2006 until the company was sold in November 2007. Mr. Merriman served as Senior Vice President and Chief Financial Officer of American Greetings Corporation (formerly, NYSE: AM), Cleveland, Ohio, a designer, manufacturer and seller of greeting cards and other social expression products from September 2005 until November 2006. He was a Director of American Greetings Corporation from 2006 through August 2013 when it became a private company. Prior to that, from August 1995 until April 2004, Mr. Merriman was the President and Chief Executive Officer of Royal Appliance Mfg. Co./ Dirt Devil Inc. (formerly, NYSE: RAM), a manufacturer of a full line of cleaning products for home and commercial use. Mr. Merriman is a Director of Nordson Corporation (Nasdaq: NDSN), Westlake, Ohio, a manufacturer of products and systems used for dispensing and processing adhesives, coatings, polymers, sealants and biomaterials; Regis Corporation (NYSE: RGS), Edina, Minnesota, a company that owns, franchises and operates beauty salons, hair restoration centers and cosmetology education; and OMNOVA Solutions Inc. (NYSE: OMN), Beachwood, Ohio, a technology-based company and an innovator of emulsion polymers, specialty chemicals, and decorative and functional surfaces.

Clifford Nastas

Mr. Clifford D. Nastas is Independent Director of the Company. He has been the President and Chief Executive Officer of Radiac Abrasives Company, a manufacturer of conventional bonded and super abrasives in North America, since January 2016. Since 2014, Mr. Nastas has been a Director of Dan T. Moore Company, Inc., a holding company of diverse advanced materials manufacturing and technology businesses and became co-chairman in 2016. Also since 2014, Mr. Nastas has served as a Director of Shorr Packaging Corporation, an ESOP-owned company that distributes packaging supplies throughout North America. Mr. Nastas served as Chief Executive Officer and a Director of Material Sciences Corporation (formerly, Nasdaq: MASC), Elk Grove Village, Illinois, a publicly traded diversified industrial manufacturing company providing high-value coated metal, acoustical and lightweight composite solutions from 2005 until the company was sold in March 2014. From 2001 to 2005, Mr. Nastas served in various capacities at Material Sciences, including as President and Chief Operating Officer. Prior to joining Material Sciences, Mr. Nastas served in various general management, sales, and manufacturing capacities with Honeywell International, formerly Allied Signal (NYSE: HON), Morris Township, New Jersey, Avery Dennison Corporation (NYSE: AVY), Glendale, California, and Ford Motor Company (NYSE: F), Dearborn, Michigan.

Baiju Shah

Mr. Baiju R. Shah is Independent Director of the Company. He has been the Chief Executive Officer and a Director of BioMotiv, LLC, a company focused on developing a portfolio of drug discoveries from research institutions into new medicines, since August 2012. Prior to that, Mr. Shah served as President and Chief Executive Officer and a Director of BioEnterprise Cleveland from 2004 to August 2012, Senior Vice President from 2003 to 2004 and a Vice President from 2002 to 2003. BioEnterprise is a Cleveland-based business formation, recruitment and acceleration initiative designed to grow health care companies and commercialize biomedical technologies. Prior to BioEnterprise, Mr. Shah worked for McKinsey & Company, where he was a leader in its Growth and Business Building practice. In addition, Mr. Shah serves as a member of the Citizens Financial Group (NYSE: CFG) advisory board. Mr. Shah also serves as a Director of multiple privately held biomedical-related companies in which BioMotiv, LLC has investments.

Lara Mahoney